MRC CiC: A new technique to measure minimal residual disease in myeloma that offers superior sensitivity, reduced cost and patient benefits

Project: Research Councils

Participants

Colleges, School and Institutes

Short titleMRC CiC: A new technique to measure minimal residual disease in myeloma that offers superior sensitivity, reduced cost and patient benefits
StatusActive
Effective start/end date1/03/2028/02/21